date
effect
treatment
bovin
cryptosporidiosi
studi
describ
use
halofuginon
lactat
prevent
cryptosporidiosi
natur
infect
neonat
calv
dairi
farm
high
preval
infect
anim
kept
two
differ
calf
rear
system
random
doubleblind
trial
carri
natur
infect
calv
divid
four
group
two
prophylact
halofuginon
lactat
treat
group
kept
either
individu
group
pen
similarli
anim
receiv
placebo
hous
either
individu
pen
togeth
larg
pen
total
ten
faecal
sampl
collect
period
day
studi
calf
test
presenc
cryptosporidium
spp
use
microscop
molecular
method
gener
estim
equat
model
use
determin
effect
variou
treatment
andor
rear
system
presenc
diarrhoea
infect
statist
signific
analysi
classif
tree
model
carri
explor
possibl
risk
factor
cryptosporidiosi
interact
treatment
rear
system
halofuginon
lactat
shown
effect
reduc
clinic
sign
cryptosporidiosi
environment
contamin
howev
treatment
delay
onset
diarrhoea
reduc
risk
infect
amongst
calv
rear
togeth
highli
contamin
environ
use
halofuginon
lactat
combin
good
hygien
measur
rear
anim
clean
individu
pen
effect
method
reduc
risk
cryptosporidiosi
amongst
day
old
calv
conclud
control
parasit
could
achiev
combin
use
effect
prevent
drug
halofuginon
lactat
good
anim
husbandri
procedur
date
effect
treatment
bovin
cryptosporidiosi
studi
describ
use
halofuginon
lactat
prevent
cryptosporidiosi
natur
infect
neonat
calv
dairi
farm
high
preval
infect
anim
kept
two
differ
calf
rear
system
random
doubleblind
trial
carri
natur
infect
calv
divid
four
group
two
prophylact
halofuginon
lactat
treat
group
kept
either
individu
group
pen
similarli
anim
receiv
placebo
hous
either
individu
pen
togeth
larg
pen
total
ten
faecal
sampl
collect
period
day
studi
calf
test
presenc
cryptosporidium
spp
use
microscop
molecular
method
gener
estim
equat
model
use
determin
effect
variou
treatment
andor
rear
system
presenc
diarrhoea
infect
statist
signific
analysi
classif
tree
model
carri
explor
possibl
risk
factor
cryptosporidiosi
interact
treatment
rear
system
halofuginon
lactat
shown
effect
reduc
clinic
sign
cryptosporidiosi
environment
contamin
howev
treatment
delay
onset
diarrhoea
reduc
risk
infect
amongst
calv
rear
togeth
highli
contamin
environ
use
halofuginon
lactat
combin
good
hygien
measur
rear
anim
clean
individu
pen
effect
method
reduc
risk
cryptosporidiosi
amongst
day
old
calv
conclud
control
parasit
could
achiev
combin
use
effect
prevent
drug
halofuginon
lactat
good
anim
husbandri
procedur
elsevi
bv
right
reserv
zoonot
apicomplexan
cryptosporidium
parvum
consid
common
enteropathogen
neonat
calv
de
la
fuent
et
al
infect
calv
exhibit
clinic
sign
rang
asymptomat
infect
profus
diarrhoea
dehydr
fayer
et
al
thompson
et
al
anim
readili
contamin
immedi
environ
total
oocyst
see
front
matter
elsevi
bv
right
reserv
output
per
infect
calf
week
fayer
et
al
major
problem
concern
c
parvum
lack
effect
mean
control
infect
decreas
environment
contamin
oocyst
oocyst
highli
resist
environment
stress
mani
disinfect
hygien
measur
suffici
avoid
infect
long
term
contamin
calf
rear
facil
odonoghu
addit
mani
drug
vaccin
evalu
potenti
therapeut
prophylact
agent
cryptosporidiosi
littl
success
halofuginon
lactat
synthet
quinazolinon
cryptosporidiostat
activ
sporozoit
merozoit
stage
c
parvum
jarvi
et
al
recommend
therapeut
prophylact
use
delay
onset
infect
reduc
shed
oocyst
decreas
sever
cryptosporidiosi
calv
joachim
et
al
jarvi
et
al
effect
prophylact
treatment
evalu
variou
calf
rear
system
use
ireland
primari
object
studi
evalu
effect
halofuginon
lactat
decreas
number
diarrhoeic
calv
kept
two
rear
system
dairi
farm
high
preval
cryptosporidiosi
amongst
neonat
calv
secondari
object
test
effect
treatment
rear
system
may
onset
diarrhoeic
sign
oocyst
shed
well
number
calv
excret
oocyst
level
excret
random
doubleblind
trial
carri
period
march
may
dairi
herd
cow
situat
co
westmeath
ireland
herd
select
basi
previou
studi
preval
c
parvum
estim
bayesian
analysi
credibl
interv
calv
unpublish
data
herd
calv
occur
throughout
year
cow
move
calv
pen
approxim
week
calv
reintroduc
milk
herd
h
calv
straw
bed
matern
pen
chang
everi
week
calv
fed
l
dam
colostrum
separ
mother
within
h
birth
commerci
vaccin
administ
cow
calv
holstein
friesian
calv
born
period
march
includ
experi
except
one
calf
die
hour
birth
newborn
calv
n
alloc
respect
experiment
group
use
tabl
random
number
first
group
consist
calv
treat
halofuginon
lactat
halocur
intervet
ireland
ltd
maintain
individu
calf
pen
second
group
also
treat
halofuginon
lactat
calv
allow
mix
freeli
larg
loos
box
third
group
consist
calv
treat
placebo
maintain
individu
calf
pen
fourth
group
treat
placebo
anim
allow
mix
freeli
larg
loos
box
tabl
time
calv
alloc
respect
experiment
group
number
calv
loos
box
increas
one
initi
final
popul
six
eight
placebo
halofuginon
lactat
treatment
group
respect
individu
calf
pen
made
aluminum
slat
wooden
base
loos
box
concret
floor
wash
disinfect
hyperox
dupont
uk
introduct
calv
floor
cover
fresh
straw
everi
day
everi
week
old
bed
remov
floor
wash
disinfect
cover
fresh
straw
placebo
solut
prepar
accord
procedur
describ
jarvi
et
al
similar
consist
color
composit
commerci
halocur
without
activ
ingredi
halofuginon
lactat
equal
volum
either
halofuginon
lactat
gkg
placebo
administ
oral
calv
morn
feed
first
day
life
first
dose
halofuginon
lactat
placebo
given
within
h
birth
colostrum
fed
anim
handler
inform
variou
treatment
administ
calv
data
collect
calf
receiv
l
whole
milk
twice
daili
water
suppli
ad
libitum
ration
contain
soya
wheat
citru
pulp
mix
farm
serum
collect
one
occas
calf
analyz
transfer
maternallyderiv
immunoglobulin
use
zinc
sulfat
test
zst
mcewan
et
al
total
ten
faecal
sampl
g
taken
calf
calv
sampl
day
thereaft
everi
second
day
day
two
sampl
collect
day
consist
faec
record
time
collect
use
follow
score
system
solid
pasti
sampl
liquid
sampl
wateri
tabl
cumul
geometr
mean
rang
oocyst
per
gram
opg
faec
excret
untreat
control
calv
calv
treat
halofuginon
lactat
first
week
rear
either
individu
group
pen
sampl
mean
faecal
score
experiment
group
calcul
take
mean
faecal
score
anim
group
sampl
point
diarrhoeic
faec
faec
score
liquid
wateri
also
test
presenc
enteropathogen
ie
escherichia
coli
salmonella
speci
rotaviru
coronaviru
faecal
sampl
g
collect
dam
within
h
calv
dust
straw
sampl
g
collect
five
differ
locat
floor
calv
pen
week
durat
experi
prior
start
experi
five
straw
sampl
g
collect
two
group
pen
addit
dust
faec
debri
g
scrape
five
differ
area
wall
group
pen
time
dust
faec
debri
g
collect
wooden
floor
aluminum
wall
individu
calf
pen
environ
sampl
collect
asept
possibl
scrape
surfac
steril
scalpel
concentr
oocyst
initi
wash
sequenti
g
calf
faec
seri
stainless
steel
siev
diminish
pore
size
final
mesh
size
oocyst
concentr
use
diethyleth
sediment
method
describ
bukhari
smith
last
wash
step
distil
water
ad
pellet
give
final
volum
ml
faecal
suspens
case
cow
sampl
start
amount
faec
g
divid
two
g
aliquot
process
describ
calf
faec
environment
sampl
initi
dilut
phosphat
buffer
salin
ph
suspens
stir
min
use
magnet
stirrer
oocyst
concentr
use
protocol
describ
faec
l
aliquot
concentr
faecal
suspens
ad
well
diamet
mm
microscop
slide
stain
l
fluorescein
isothiocyan
fitc
conjug
anticryptosporidium
monoclon
antibodi
cellab
pti
ltd
australia
use
procedur
describ
mcevoy
et
al
smear
examin
magnif
use
fluoresc
microscop
olympu
japan
contain
filter
cube
emiss
nm
excit
wavelength
nm
slide
consid
posit
least
one
cryptosporidium
oocyst
identifi
posit
slide
approxim
number
oocyst
per
gram
faec
opg
calcul
use
mean
number
oocyst
present
ten
randomli
chosen
field
magnif
correct
total
surfac
well
dilut
origin
sampl
correct
made
consist
diarrhoeic
sampl
trapezium
rule
appli
success
sampl
episod
estim
number
oocyst
excret
calv
period
experi
whittak
robinson
calf
valu
obtain
interv
sampl
ad
give
cumul
amount
oocyst
entir
period
experi
cumul
amount
oocyst
obtain
calf
use
calcul
geometr
mean
cumul
amount
oocyst
per
gram
excret
four
experiment
group
calv
period
studi
dna
extract
commerci
kit
fastdna
spin
kit
soil
qbiogen
inc
usa
l
faecal
suspens
obtain
concentr
oocyst
cryptosporidium
spp
dna
detect
use
nest
pcr
amplifi
segment
small
subunit
rrna
gene
approxim
bp
xiao
et
al
secondari
pcr
product
seven
randomli
chosen
posit
faecal
sampl
posit
environment
sampl
sequenc
identifi
genotyp
isol
present
farm
addit
sampl
test
use
anoth
nest
pcr
amplifi
bp
fragment
glycoprotein
gene
alv
et
al
similarli
secondari
pcr
product
assay
also
sequenc
identifi
subgenotyp
c
parvum
isol
posit
cryptosporidium
dna
templat
neg
control
includ
everi
pcr
assay
purif
sequenc
amplicon
carri
commerci
compani
mwg
biotech
ag
germani
amplifi
pcr
product
sequenc
direct
use
forward
revers
primer
secondari
pcr
sequenc
assembl
edit
align
refer
sequenc
genbank
use
lasergen
softwar
dnastar
inc
madison
usa
recent
propos
nomenclatur
use
label
c
parvum
subtyp
sulaiman
et
al
result
analyz
statamp
softwar
stata
corpor
colleg
station
texa
usa
sampl
point
correl
categor
variabl
eg
diarrhoea
infect
treatment
locat
sex
assess
fisher
exact
test
correl
continu
variabl
eg
valu
zst
level
oocyst
excret
assess
spearman
correl
coeffici
nonparametr
method
kaplanmei
method
use
creat
survivor
function
visual
compar
group
calv
onset
diarrhoea
oocyst
shed
kaplan
meier
four
statist
test
ie
logrank
test
wilcoxon
test
taronewar
test
petopetoprentic
harringtonflem
test
conduct
test
signific
differ
p
survivor
function
differ
among
four
test
depend
weight
use
combin
estim
deriv
point
time
dohoo
et
al
gener
estim
equat
model
gee
use
test
signific
effect
p
treatment
rear
system
may
number
diarrhoeic
calv
calv
shed
oocyst
also
level
oocyst
excret
take
account
repeat
observ
anim
dohoo
et
al
dichotom
outcom
binomi
famili
logist
link
exchang
correl
matrix
assum
continu
outcom
poisson
famili
log
link
exchang
correl
matrix
select
johnson
et
al
altern
analyt
nonlinear
nonparametr
approach
describ
duc
thang
et
al
also
conduct
use
classif
regress
tree
cart
softwar
explor
possibl
risk
factor
cryptosporidiosi
identifi
interact
treatment
calfrear
regim
cart
model
fit
binari
recurs
partit
multidimension
covari
space
dataset
success
split
increasingli
homogen
subset
specifi
criterion
satisfi
duc
thang
et
al
onestandard
error
rule
appli
select
best
tree
cart
model
use
indic
interact
treatment
calfrear
regim
take
account
cluster
effect
within
calv
total
calv
use
studi
male
result
zinc
sulfat
turbid
test
unit
calv
indic
receiv
suffici
quantiti
colostrum
anim
neg
cryptosporidium
sp
birth
result
microscopi
sequenc
analys
indic
major
calv
infect
c
parvum
subtyp
stage
experi
except
one
halofuginon
treat
calf
kept
individu
pen
remain
free
infect
durat
studi
advers
reaction
medic
halofuginon
lactat
treat
calv
ie
mortal
clinic
find
dehydr
prostrat
presenc
mucu
visibl
blood
faec
record
calv
treat
halofuginon
lactat
studi
e
coli
detect
faec
three
calv
age
week
old
placebo
group
one
rear
individu
pen
two
other
rear
loos
pen
also
infect
c
parvum
three
placebo
treat
calv
week
old
one
rear
individu
pen
two
other
rear
loos
pen
die
experi
anim
subject
postmortem
examin
determin
caus
dead
base
gross
patholog
lesion
two
calv
die
result
respiratori
infect
one
due
acut
enter
concentr
cryptosporidium
oocyst
per
gram
faec
common
enteropathogen
detect
anim
pcr
assay
carri
faecal
sampl
collect
cow
neg
cryptosporidium
spp
dna
addit
evid
cow
contamin
environ
oocyst
environment
sampl
calv
pen
also
neg
howev
environment
sampl
floor
two
wall
loos
calf
pen
posit
cryptosporidium
spp
dna
pcr
assay
contrast
major
sampl
collect
individu
calf
pen
neg
except
two
pen
two
pen
blindli
assign
calv
halofuginon
lactat
treatment
group
calv
two
pen
excret
oocyst
day
age
sequenc
environment
isol
identifi
c
parvum
subtyp
major
calv
receiv
placebo
infect
within
first
week
age
rang
day
mean
age
onset
infect
calv
treat
halofuginon
lactat
day
rang
day
p
illustr
kaplanmei
surviv
estim
calv
receiv
placebo
becam
diarrhoeic
earlier
calv
receiv
halofuginon
lactat
mean
age
day
rang
day
day
rang
day
respect
fig
differ
statist
confirm
four
test
ie
logrank
wilcoxon
taronewar
petopetoprentic
harringtonflem
use
test
whether
overal
survivor
function
group
equal
p
event
diarrhoea
petopetoprentic
harringtonflem
test
appropri
test
compar
kaplanmei
curv
treat
control
group
anim
test
take
account
differ
censor
pattern
group
case
diarrhoea
detect
five
calv
treat
halofuginon
lactat
placebo
calv
diarrhoea
stage
experi
tabl
one
calf
censor
event
infect
therefor
logrank
test
assign
equal
weight
time
point
select
tabl
signific
correl
diarrhoea
infect
found
compar
experiment
group
treat
halofuginon
lactat
placebo
age
day
p
addit
correl
infect
treatment
receiv
found
calv
age
day
p
day
p
day
p
analysi
pcr
ifa
result
use
gee
model
indic
halofuginon
lactat
significantli
reduc
number
diarrhoeic
calv
infect
calv
oocyst
excret
calv
p
tabl
fig
illustr
pattern
mean
faecal
score
group
treat
placebo
calv
peak
oocyst
product
mean
circa
oocyst
per
gram
faec
amongst
untreat
calv
occur
day
age
addit
cumul
geometr
mean
number
oocyst
per
gram
faec
higher
placebo
calv
treat
calv
tabl
howev
day
halofuginon
treat
calv
shed
albeit
low
number
oocyst
untreat
calv
fig
comparison
mean
faecal
score
calv
maintain
either
individu
pen
group
pen
treat
either
halofuginon
lactat
placebo
fig
age
one
infect
treat
calv
diarrhoeic
halofuginon
lactat
significantli
reduc
number
diarrhoeic
calv
oocyst
excret
calv
group
pen
tabl
fig
howev
time
onset
diarrhoea
statist
differ
treat
placebo
calv
one
treat
calv
excret
oocyst
medic
calv
found
shed
oocyst
stage
experi
nestedpcr
assay
use
detect
method
fig
correl
number
calv
excret
oocyst
treatment
receiv
found
calv
age
day
p
cumul
geometr
mean
number
oocyst
per
gram
faec
higher
placebo
calv
treat
calv
tabl
compar
two
placebo
group
signific
differ
onset
clinic
sign
infect
number
infect
diarrhoeic
calv
observ
two
rear
system
tabl
one
calf
group
pen
excret
oocyst
earli
day
old
addit
amount
oocyst
excret
placebo
calv
group
pen
significantli
greater
amount
shed
calv
individu
pen
p
tabl
compar
two
halofuginon
lactat
group
time
onset
oocyst
excret
reduc
calv
kept
individu
pen
p
tabl
maintain
treat
calv
individu
pen
significantli
reduc
number
anim
infect
cryptosporidium
amount
oocyst
excret
p
tabl
gee
model
indic
signific
interact
halofuginon
lactat
treatment
individu
pen
reduc
proport
infect
calv
p
number
oocyst
excret
p
tabl
accord
overal
discriminatori
power
cart
analysi
age
strongest
overal
risk
factor
cryptosporidiosi
follow
treatment
hous
system
cart
model
suggest
among
treat
calv
age
day
old
rear
system
import
risk
factor
fig
abridg
version
studi
publish
previous
abbrevi
result
use
recent
review
metaanalys
effect
halofuginon
lactat
treat
prevent
neonat
cryptosporidiosi
de
wael
et
al
silverla
et
al
present
studi
evalu
prophylact
benefit
halofuginon
lactat
cryptosporidiosi
two
differ
calf
rear
system
infect
farm
result
analyz
use
kaplanmei
gee
model
addit
cart
model
use
highlight
interact
variou
risk
factor
associ
neonat
cryptosporidiosi
primari
sourc
infect
experiment
calv
surmis
howev
possibl
initi
exposur
infect
calv
pen
appear
unlik
oocyst
detect
faecal
environment
sampl
taken
cow
calv
pen
respect
contrast
previou
studi
suggest
cow
sourc
infect
calv
due
periparturi
rise
oocyst
excret
result
contamin
calv
pen
garber
et
al
castrohermida
et
al
result
confirm
previou
report
calv
rear
good
hygien
condit
disinfect
individu
calf
pen
halofuginon
lactat
effect
delay
onset
cryptosporidium
infect
diarrhoea
reduc
number
calv
becom
infect
exhibit
sign
enter
decreas
level
oocyst
excret
lefay
et
al
jarvi
et
al
klein
delay
onset
diarrhoea
import
newborn
calv
suscept
dehydr
acidbas
balanc
disturb
sinc
risk
decreas
age
prevent
use
halofuginon
lactat
may
delay
infect
onset
clinic
sign
age
anim
better
abl
cope
pathogen
affect
parasit
addit
benefit
halofuginon
lactat
treatment
reduct
number
infect
anim
exhibit
sign
enter
amount
oocyst
excret
joachim
et
al
lallemand
et
al
shown
current
studi
efficaci
halofuginon
lactat
decreas
calv
maintain
less
optim
condit
mix
togeth
group
pen
benefit
good
husbandri
also
evid
placebo
group
compar
calv
rear
individu
pen
excret
significantli
less
oocyst
calv
kept
group
pen
week
major
treat
calv
excret
oocyst
albeit
low
level
socal
rebound
phenomenon
report
previou
worker
lallemand
et
al
observ
studi
gener
consid
limit
clinic
consequ
markedli
increas
cumul
amount
oocyst
produc
treat
calv
explan
occurr
might
includ
reinfect
activ
autoinfect
phase
thinwal
oocyst
andor
reactiv
inhibit
stage
villacorta
et
al
naciri
et
al
anoth
possibl
older
calv
may
infect
differ
cryptosporidium
speci
howev
sequenc
gene
gene
fragment
carri
isol
faecal
sampl
collect
calv
exhibit
rebound
phenomenon
indic
c
parvum
subtyp
prevail
cryptosporidium
strain
amongst
experiment
calv
calv
receiv
placebo
show
evid
recrudesc
oocyst
excret
day
may
attribut
degre
acquir
resist
initi
infect
statist
model
use
analyz
experiment
data
highlight
need
integr
control
programm
combin
good
anim
husbandri
measur
prophylact
use
halofuginon
lactat
reduc
risk
neonat
cryptosporidiosi
henc
indic
cart
model
treat
calv
age
seven
day
risk
infect
rear
group
pen
individu
pen
addit
cart
model
identifi
age
calf
strongest
discrimin
risk
factor
bovin
cryptosporidiosi
calv
day
old
like
infect
younger
anim
whether
receiv
halofuginon
lactat
silverla
et
al
came
conclus
metaanalysi
data
number
previou
studi
worker
also
report
similar
age
predisposit
suscept
calv
cryptosporidiosi
kvac
et
al
therefor
recommend
separ
rear
calv
agegroup
base
level
suscept
thu
newborn
calv
mix
calv
seven
day
old
size
experiment
group
base
number
calv
born
farm
alloc
period
feasibl
complet
laboratori
test
reason
time
period
also
number
anim
use
previou
studi
treatment
calv
halofuginon
lactat
peeter
et
al
jarvi
et
al
limit
number
calv
experiment
group
affect
statist
power
detect
benefici
effect
halofuginon
lactat
treatment
husbandri
practic
includ
calf
rear
facil
farm
experi
carri
typic
larg
dairi
herd
ireland
histori
neonat
enter
preval
cryptosporidiosi
amongst
young
calv
estim
unpublish
data
throughout
design
implement
studi
everi
effort
made
ensur
would
possibl
extrapol
result
calf
rear
practic
major
irish
dairi
farm
studi
could
form
basi
larger
studi
number
farm
futur
conclus
halofuginon
lactat
shown
effect
reduc
clinic
sign
cryptosporidiosi
environment
contamin
cryptosporidium
oocyst
howev
control
parasit
achiev
integr
measur
mix
anim
differ
age
place
newborn
calv
uncontamin
environ
prophylact
use
drug
halofuginon
lactat
effect
onfarm
control
programm
addit
benefit
anim
health
directli
also
indirectli
benefit
public
health
concentr
oocyst
slurri
runoff
water
calf
hous
markedli
lower
thu
reduc
risk
surfac
water
contamin
oocyst
zoonot
cryptosporidium
speci
fayer
et
al
